Workflow
NMN概念
icon
Search documents
兄弟科技涨2.01%,成交额3937.49万元,主力资金净流入115.89万元
Xin Lang Cai Jing· 2025-11-25 02:43
今年以来兄弟科技已经9次登上龙虎榜,最近一次登上龙虎榜为9月25日,当日龙虎榜净买入-5801.97万 元;买入总计1.27亿元 ,占总成交额比7.06%;卖出总计1.85亿元 ,占总成交额比10.28%。 11月25日,兄弟科技盘中上涨2.01%,截至10:06,报6.59元/股,成交3937.49万元,换手率0.86%,总市 值75.31亿元。 资金流向方面,主力资金净流入115.89万元,大单买入483.60万元,占比12.28%,卖出367.71万元,占 比9.34%。 兄弟科技今年以来股价涨55.06%,近5个交易日跌5.72%,近20日跌7.57%,近60日跌2.66%。 责任编辑:小浪快报 分红方面,兄弟科技A股上市后累计派现3.90亿元。近三年,累计派现1.06亿元。 机构持仓方面,截止2025年9月30日,兄弟科技十大流通股东中,国泰中证畜牧养殖ETF(159865)位 居第三大流通股东,持股1413.11万股,相比上期增加504.55万股。招商中证畜牧养殖ETF(516670)位 居第九大流通股东,持股204.98万股,为新进股东。 资料显示,兄弟科技股份有限公司位于浙江省海宁市海洲街道学 ...
金达威跌2.02%,成交额4367.22万元,主力资金净流入11.37万元
Xin Lang Cai Jing· 2025-11-21 02:40
Core Viewpoint - The stock of Kingdawei has experienced a decline recently, with a notable drop in trading volume and fluctuations in shareholder numbers, despite a year-to-date increase in stock price and significant growth in revenue and net profit [1][2]. Financial Performance - For the period from January to September 2025, Kingdawei achieved a revenue of 2.604 billion yuan, representing a year-on-year growth of 11.16% [2]. - The net profit attributable to shareholders for the same period was 361 million yuan, showing a substantial increase of 63.47% compared to the previous year [2]. Stock Market Activity - As of November 21, Kingdawei's stock price was 18.96 yuan per share, with a market capitalization of 11.564 billion yuan [1]. - The stock has increased by 28.98% year-to-date, but has seen a decline of 9.11% over the last five trading days [1]. Shareholder Information - As of September 30, the number of shareholders for Kingdawei was 36,300, a decrease of 10.95% from the previous period [2]. - The average number of circulating shares per shareholder increased by 12.29% to 16,817 shares [2]. Dividend Distribution - Kingdawei has distributed a total of 2.761 billion yuan in dividends since its A-share listing, with 488 million yuan distributed over the last three years [3]. Institutional Holdings - As of September 30, 2025, Hong Kong Central Clearing Limited was the fourth largest circulating shareholder, holding 7.7408 million shares, an increase of 803,600 shares from the previous period [3]. - The Southern CSI 1000 ETF and Huaxia CSI 1000 ETF were among the top ten circulating shareholders, with slight changes in their holdings [3].
特一药业跌2.02%,成交额2.60亿元,主力资金净流出1489.08万元
Xin Lang Cai Jing· 2025-11-20 02:50
Core Viewpoint - The stock of Te Yi Pharmaceutical has experienced fluctuations, with a recent decline of 2.02% and a year-to-date increase of 35.94%, indicating volatility in its market performance [1]. Company Performance - As of September 30, 2025, Te Yi Pharmaceutical reported a revenue of 6.92 billion yuan, representing a year-on-year growth of 51.86%, and a net profit attributable to shareholders of 652.17 million yuan, which is a significant increase of 985.18% compared to the previous year [2]. - The company has distributed a total of 1.059 billion yuan in dividends since its A-share listing, with 356 million yuan distributed over the past three years [3]. Stock Market Activity - The stock price of Te Yi Pharmaceutical is currently at 12.10 yuan per share, with a trading volume of 2.60 billion yuan and a turnover rate of 5.62%, leading to a total market capitalization of 6.207 billion yuan [1]. - The stock has appeared on the "Dragon and Tiger List" 11 times this year, with the most recent appearance on November 17, where it recorded a net buy of -733.44 million yuan [1]. Shareholder Information - As of September 30, 2025, the number of shareholders for Te Yi Pharmaceutical increased to 58,100, a rise of 10.11%, while the average circulating shares per person decreased by 9.09% to 6,481 shares [2]. - Among the top ten circulating shareholders, notable positions include the "Xingquan Zhongzheng 800 Six-Month Holding Index Enhanced A" and "Xingquan Hu-Shen 300 Index Enhanced (LOF) A," which maintained their holdings [3].
众生药业跌2.02%,成交额8.97亿元,主力资金净流出6726.74万元
Xin Lang Zheng Quan· 2025-11-20 02:36
Core Viewpoint - The stock of Zhongsheng Pharmaceutical has experienced fluctuations, with a recent decline of 2.02% and a total market capitalization of 18.936 billion yuan, despite an overall increase of 86.44% year-to-date [1] Financial Performance - For the period from January to September 2025, Zhongsheng Pharmaceutical reported a revenue of 1.889 billion yuan, a year-on-year decrease of 1.01%, while the net profit attributable to shareholders increased by 68.40% to 251 million yuan [2] - The company has cumulatively distributed 2.019 billion yuan in dividends since its A-share listing, with 502 million yuan distributed over the past three years [3] Stock Market Activity - The stock has seen significant trading activity, with a net outflow of 67.267 million yuan in major funds recently, and it has appeared on the trading leaderboard seven times this year [1] - The stock price has fluctuated, with a recent 5-day decline of 5.75% and a 20-day increase of 20.89% [1] Shareholder Structure - As of September 30, 2025, the number of shareholders decreased by 18.90% to 72,900, while the average number of circulating shares per person increased by 23.31% to 10,445 shares [2] - Notable institutional shareholders include Hong Kong Central Clearing Limited and several funds from Xingquan, indicating a mix of new and increasing positions among major shareholders [3]
金达威跌2.00%,成交额1.17亿元,主力资金净流出948.22万元
Xin Lang Cai Jing· 2025-11-19 06:10
Core Viewpoint - The stock of Kingdawei has experienced fluctuations, with a recent decline of 2.00% and a year-to-date increase of 33.27%, indicating volatility in its market performance [1]. Financial Performance - As of September 30, Kingdawei reported a revenue of 2.604 billion yuan, representing a year-on-year growth of 11.16% [2]. - The net profit attributable to shareholders for the same period was 361 million yuan, showing a significant increase of 63.47% year-on-year [2]. Shareholder Information - The number of shareholders as of September 30 is 36,300, a decrease of 10.95% from the previous period [2]. - The average circulating shares per person increased by 12.29% to 16,817 shares [2]. Dividend Distribution - Kingdawei has distributed a total of 2.761 billion yuan in dividends since its A-share listing, with 488 million yuan distributed over the past three years [3]. Institutional Holdings - As of September 30, the fourth largest circulating shareholder is Hong Kong Central Clearing Limited, holding 7.7408 million shares, an increase of 803,600 shares from the previous period [3]. - The seventh largest circulating shareholder is Southern CSI 1000 ETF, holding 2.7924 million shares, which decreased by 20,500 shares [3]. - The tenth largest circulating shareholder is Huaxia CSI 1000 ETF, holding 1.6575 million shares, with a reduction of 4,900 shares [3].
红太阳跌2.08%,成交额3302.25万元,主力资金净流出591.82万元
Xin Lang Zheng Quan· 2025-11-19 02:04
11月19日,红太阳盘中下跌2.08%,截至09:54,报6.11元/股,成交3302.25万元,换手率0.54%,总市值 79.31亿元。 资金流向方面,主力资金净流出591.82万元,特大单买入0.00元,占比0.00%,卖出499.94万元,占比 15.14%;大单买入480.41万元,占比14.55%,卖出572.29万元,占比17.33%。 红太阳所属申万行业为:基础化工-农化制品-农药。所属概念板块包括:摘帽概念、草甘膦、NMN概 念、低价、生物农药等。 截至10月20日,红太阳股东户数4.33万,较上期减少2.91%;人均流通股22852股,较上期增加2.99%。 2025年1月-9月,红太阳实现营业收入23.28亿元,同比减少13.87%;归母净利润-2.72亿元,同比减少 1115.05%。 分红方面,红太阳A股上市后累计派现11.46亿元。近三年,累计派现0.00元。 责任编辑:小浪快报 红太阳今年以来股价涨2.35%,近5个交易日跌3.17%,近20日跌6.43%,近60日跌11.83%。 今年以来红太阳已经3次登上龙虎榜,最近一次登上龙虎榜为6月18日,当日龙虎榜净买入-4983.72 ...
精工钢构跌2.07%,成交额4636.15万元,主力资金净流出8404.00元
Xin Lang Cai Jing· 2025-11-17 01:59
11月17日,精工钢构盘中下跌2.07%,截至09:48,报4.25元/股,成交4636.15万元,换手率0.54%,总市 值84.58亿元。 资金流向方面,主力资金净流出8404.00元,大单买入1116.12万元,占比24.07%,卖出1116.96万元,占 比24.09%。 精工钢构今年以来股价涨44.56%,近5个交易日跌1.62%,近20日跌0.93%,近60日涨27.63%。 资料显示,长江精工钢结构(集团)股份有限公司位于上海市闵行区黎安路999号大虹桥国际32层,成立 日期1999年6月28日,上市日期2002年6月5日,公司主营业务涉及钢结构建筑的设计、制作、安装和工 程服务业务。主营业务收入构成为:钢结构行业92.32%,集成及EPC5.85%,其他1.83%。 精工钢构所属申万行业为:建筑装饰-专业工程-钢结构。所属概念板块包括:低市盈率、破净股、世界 杯、低价、NMN概念等。 截至9月30日,精工钢构股东户数7.84万,较上期减少8.29%;人均流通股25398股,较上期增加9.04%。 2025年1月-9月,精工钢构实现营业收入145.57亿元,同比增长20.85%;归母净利润5.9 ...
西王食品涨2.02%,成交额1.05亿元,主力资金净流入55.88万元
Xin Lang Cai Jing· 2025-11-13 07:00
Group 1 - The core viewpoint of the news is that Xiwang Food's stock has shown a recent upward trend despite a year-to-date decline, with significant trading activity and changes in shareholder structure [1][2]. - As of November 13, Xiwang Food's stock price increased by 2.02% to 3.54 CNY per share, with a total market capitalization of 3.821 billion CNY [1]. - The company has experienced a year-to-date stock price decline of 1.67%, but has seen a 7.60% increase over the last five trading days and a 14.94% increase over the last 20 days [1]. Group 2 - For the period from January to September 2025, Xiwang Food reported a revenue of 3.507 billion CNY, representing a year-on-year decrease of 8.04%, and a net profit attributable to shareholders of 2.2219 million CNY, down 96.45% year-on-year [2]. - The company has a total of 46,900 shareholders as of September 30, which is a decrease of 19.99% from the previous period, while the average circulating shares per person increased by 24.99% to 22,997 shares [2]. - Xiwang Food has cumulatively distributed 370 million CNY in dividends since its A-share listing, with no dividends paid in the last three years [3].
红太阳涨2.22%,成交额4573.54万元,主力资金净流出238.43万元
Xin Lang Cai Jing· 2025-11-12 02:18
Group 1 - The core viewpoint of the news is that Hongyang's stock has shown fluctuations in price and trading volume, with a notable increase of 2.22% on November 12, reaching 6.46 CNY per share, and a total market capitalization of 8.385 billion CNY [1] - As of October 20, the number of shareholders for Hongyang decreased to 43,300, a reduction of 2.91%, while the average circulating shares per person increased by 2.99% to 22,852 shares [2] - Hongyang's main business involves the research and production of new environmentally friendly pesticides, with pesticide sales accounting for 96.95% of its total revenue [1][2] Group 2 - In the first nine months of 2025, Hongyang reported operating revenue of 2.328 billion CNY, a year-on-year decrease of 13.87%, and a net profit attributable to shareholders of -272 million CNY, a significant decline of 1115.05% [2] - The company has cumulatively distributed dividends of 1.146 billion CNY since its A-share listing, with no dividends paid in the last three years [3]
西王食品涨2.06%,成交额1.15亿元,主力资金净流入421.99万元
Xin Lang Zheng Quan· 2025-11-11 06:15
Core Viewpoint - Xiwang Food's stock price has shown fluctuations with a recent increase, but the company has faced a decline in revenue and net profit year-on-year, indicating potential challenges ahead [1][2]. Financial Performance - As of September 30, Xiwang Food reported a revenue of 3.507 billion yuan, a year-on-year decrease of 8.04% [2]. - The net profit attributable to shareholders was 2.2219 million yuan, reflecting a significant year-on-year decline of 96.45% [2]. - The company's stock price has decreased by 3.89% year-to-date, but it has increased by 4.53% in the last five trading days and 11.97% over the last 20 days [1]. Shareholder Information - The number of shareholders as of September 30 was 46,900, a decrease of 19.99% from the previous period [2]. - The average number of circulating shares per shareholder increased by 24.99% to 22,997 shares [2]. Dividend Information - Xiwang Food has cumulatively distributed 370 million yuan in dividends since its A-share listing, with no dividends paid in the last three years [3]. Company Overview - Xiwang Food, established on January 31, 2011, and listed on November 26, 1996, is located in Zouping City, Shandong Province [1]. - The company's main business includes the production and sale of corn oil, as well as the research, production, and sale of sports nutrition and weight management products [1]. - The revenue composition is as follows: nutritional supplements 44.83%, plant oil 44.47%, and others 10.70% [1]. Industry Classification - Xiwang Food is classified under the Shenwan industry as food and beverage - food processing - health products [1]. - The company is associated with several concept sectors, including small-cap, low-price, supply and marketing cooperatives, NMN concept, and margin trading [1].